Table 2.

Relationship between the relative expression of preoperative serum miR-200a and clinicopathological features. *P<0.05, ***P<0.001.

Pathology characteristics		Case	Preoperative serum miR-200a
			Median	P value
Total		20
Gender	male	15	0.350	0.1374
	Female	5	0.480
Age (years old)	<55	12	0.365	0.9378
	≥55	8	0.325
ALT (U/L)	<40	18	0.360	0.1225
	≥40	2	0.625
Viral infection (HBV or HCV)	Positive	11	0.370	0.9326
	Negative	9	0.360
AFP serum level (ng/ml)	0-20	10	0.375	0.7245
	>20	10	0.265
Liver cirrhosis	Positive	11	0.370	0.8355
	Negative	9	0.360
Tumor size (cm)	<5	14	0.380	0.0327*
	≥5	6	0.140
TNM stage	0~II	13	0.380	0.0463*
	III~IV	7	0.180
Differentiation	Middle or well	13	0.380	0.0190*
	Poor	7	0.100
Metastasis	Positive	7	0.100	0.0190*
	Negative	13	0.380
Recurrence	Positive	3	0.070	<0.001***
	Negative	17	0.370